| SIRNA-BASED COMPOSITION FOR INHIBITING Gal-9 (LGALS9), PREPARATION BASED THEREON AND METHOD OF USING IT AS TARGETED IMMUNOSTIMULANT IN ANTI-PD-L1 THERAPY | |
| 2023-12-22 | |
| 专利权人 | SUPERHARD & NEW CARBON MATERIALS INST (SUPE-Non-standard) |
| 申请日期 | 2023-12-22 |
| 专利号 | RU2832798-C1 |
| 成果简介 | NOVELTY - Group of inventions relates to pharmaceutics and medicine. Object 1 is a composition for enhancing the T-cell immune response by blocking the function of the LGALS9 gene in kidney cancer cells, comprising an agent for delivering short interfering RNAs (siRNA) to target cells, which is liposomes 1,26-bis(cholest-5-en-3β-yloxycarbonylamino)-7,11,16-2-tetraazagexacosane tetrahydrochloride (2X3):1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) in molar ratio of 1:2, and duplex to the LGALS9 gene, formed by two oligonucleotides and containing nucleotide sequences of short interfering RNA. Object 2 – corresponding preparation based on said compositioncharacterized by the fact that it contains a duplex to the LGALS9 gene, cationic liposomes 2X3:DOPE in molar ratio of 1:2, sodium chloride and polysorbate 80. Object 3 – use of the composition for enhancing the T-cell immune response in avelumab therapy. USE - Pharmaceutics; medicine. ADVANTAGE - Enhancing the T-cell immune response as a result of increasing the number of effective T-cells capable of initiating the destruction of tumour cells, as well as delivering nucleic acids into the cells and suppressing the LGALS9 gene expressed in tumour cells both in mono-mode and in the treatment with avelumab. 6 cl, 8 dwg, 2 tbl, 4 ex |
| IPC 分类号 | A61K-031/7115 ; A61K-047/24 ; A61K-047/26 ; A61P-035/00 ; C12N-015/113 |
| 国家 | 俄罗斯 |
| 专业领域 | 生物科学 |
| 语种 | 英语 |
| 成果类型 | 专利 |
| 文献类型 | 科技成果 |
| 条目标识符 | http://119.78.100.226:8889/handle/3KE4DYBR/18788 |
| 专题 | 中国科学院新疆生态与地理研究所 |
| 作者单位 | SUPERHARD & NEW CARBON MATERIALS INST (SUPE-Non-standard) |
| 推荐引用方式 GB/T 7714 | ALIMOV A A,KUZEVANOVA A I,APANOVICH N V,et al. SIRNA-BASED COMPOSITION FOR INHIBITING Gal-9 (LGALS9), PREPARATION BASED THEREON AND METHOD OF USING IT AS TARGETED IMMUNOSTIMULANT IN ANTI-PD-L1 THERAPY. RU2832798-C1[P]. 2023. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论